BBLG
Bone Biologics
BBLG
BBLG
6 hedge funds and large institutions have $576K invested in Bone Biologics in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Holders
6
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$381K | |
| 2 | +$36.9K | |
| 3 | +$23K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$8.23K |
Top Sellers
| 1 | -$56.2K | |
| 2 | -$25K | |
| 3 | -$11.3K | |
| 4 |
Millennium Management
New York
|
-$5K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$13 |